Steve Lee(@steveleeyc) 's Twitter Profileg
Steve Lee

@steveleeyc

Medical oncologist @permanentedocs and weekend warrior. Tweets mine, RT ≠ endorsement, nothing is medical advice.

ID:229309462

calendar_today22-12-2010 02:34:07

541 Tweets

429 Followers

402 Following

Steve Lee(@steveleeyc) 's Twitter Profile Photo

Excellent lung cancer panel at ANCO ; seems that Bristol Myers Squibb needs to do some detailing on how to pronounce nivolumab. NEE-vo vs nih-vo? Luu-mab vs LYOO-mab?

Excellent lung cancer panel at @ANCO_News #MMC2024; seems that @bmsnews needs to do some detailing on how to pronounce nivolumab. NEE-vo vs nih-vo? Luu-mab vs LYOO-mab?
account_circle
Steve Lee(@steveleeyc) 's Twitter Profile Photo

'Impact cancer care today?'😅I get how US News Rankings cancer hospital rankings are nice for reputation/revenue, but this Moffitt Cancer Center Cancer Center appeal takes it too far. A fifth vote instead for, say, NYU hurts cancer progress? How'd they even get my email?

'Impact cancer care today?'😅I get how @USNewsRanks cancer hospital rankings are nice for reputation/revenue, but this @MoffittNews Cancer Center appeal takes it too far. A fifth vote instead for, say, NYU hurts cancer progress? How'd they even get my email?
account_circle
Steve Lee(@steveleeyc) 's Twitter Profile Photo

Identified by ⁦ASCO⁩ advocates, recent ⁦AMA⁩ policy urges CMS to change barriers to out-of-network clinical trial enrollment, as described by ⁦Meera Ragavan, MD MPH⁩ of ⁦PermanenteDoctors⁩ ⁦⁦Kaiser Permanente Research NorCal⁩ tinyurl.com/6xytyh8f

Identified by ⁦@ASCO⁩ advocates, recent ⁦@AmerMedicalAssn⁩ policy urges CMS to change #MedicareAdvantage barriers to out-of-network clinical trial enrollment, as described by ⁦@meera_ragavan⁩ of ⁦@PermanenteDocs⁩ ⁦⁦@KPDOR⁩ tinyurl.com/6xytyh8f
account_circle
Steve Lee(@steveleeyc) 's Twitter Profile Photo

Physician complaints stoked legislative interest in mitigating drug shortages, said ASH Congressional Fellow Camille Puronen at PermanenteDoctors EICC cancer conference.

Physician complaints stoked legislative interest in mitigating drug shortages, said @ASH_hematology Congressional Fellow @CPuronen at @PermanenteDocs EICC cancer conference.
account_circle
Jason Westin, MD FACP(@Lymphoma_Doc) 's Twitter Profile Photo

Great day of with the talented volunteers and staff of ASCO Government Relations Committee. Come join us on Capitol Hill April 16-17!

Great day of #ASCOAdvocacy with the talented volunteers and staff of @ASCO Government Relations Committee. Come join us on Capitol Hill April 16-17!
account_circle
Steve Lee(@steveleeyc) 's Twitter Profile Photo

Sticker-price inpatient CAR-T is prohibitively expensive, but outpatient administration with discounts might push down costs to make 2L therapy worthwhile. And super lucrative for hospital-based oncology practices Amar Kelkar, MD, MPH, FACP

account_circle
Ray Page, DO PhD(@RayPageDOPhD) 's Twitter Profile Photo

Hard working ASCO delegation to the AMA. We were 3/3 with adoption of ASCO sponsored resolutions regarding AMA advocacy for access to clinical trials for MEDICARE advantage patients, modernizing remote digital lab access under CLIA, and managing ERISA laws with PBMs

Hard working @ASCO delegation to the AMA. We were 3/3 with adoption of ASCO sponsored resolutions regarding AMA advocacy for access to clinical trials for MEDICARE advantage patients, modernizing remote digital lab access under CLIA, and managing ERISA laws with PBMs
account_circle
Lynn M. Schuchter, MD, FASCO(@ASCOPres) 's Twitter Profile Photo

Congratulations to Dr. Monica Bertagnolli on her confirmation as NIH Director. A truly extraordinary leader for this role. Looking forward to ongoing collaboration with the NIH.

account_circle